PHYSICIAN ADHERENCE TO PUBLISHED GUIDELINES IN PRESCRIBING ANTI-ARRHYTHMIC MEDICATIONS IN THE MANAGEMENT OF ATRIAL FIBRILLATION  by Leef, George et al.
Arrhythmias and Clinical EP
A387
JACC March 17, 2015
Volume 65, Issue 10S
physiCian adhErEnCE to publishEd guidElinEs in prEsCribing anti-arrhythMiC 
MEdiCations in thE ManagEMEnt of atrial fibrillation
Poster Contributions
Poster Hall B1
Sunday, March 15, 2015, 9:45 a.m.-10:30 a.m.
Session Title: What Constitutes Anti Arrhythmic Therapy for Atrial Fibrillation?
Abstract Category: 4. Arrhythmias and Clinical EP: AF/SVT
Presentation Number: 1186-250
Authors: George Leef, Dingxin Qin, Mian Bilal Alam, Rohit Rattan, Muhammad Bilal Munir, Divyang Patel, Furqan Habib Khattak, Nishit 
Vaghasia, Sandeep Jain, Samir Saba, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
background:  Although guidelines for anti-arrhythmic therapy (AAD) in atrial fibrillation (AF) were published in 2006, there is still paucity of 
data on how well these guidelines are implemented. We therefore investigated the degree of adherence to these guidelines among primary 
care physicians (PCP), general cardiologists (GC), and cardiac electrophysiologists (EP). 
Methods:  Between 2006 and 2013, 5976 patients (age=70±12 years; men 59%; coronary disease 36%; hypertension 64%; CHADS2-vasc 
score=2.9±1.8), with AF who were prescribed at least 1 AAD at our institution. The primary specialty of the AAD prescriber was ascertained 
for 4605 (77%) patients (PCP=249 (5%), GC=3018 (66%), EP=1338 (29%)) for the first prescribed AAD. 
results:  Overall adherence with guidelines for the cohort was 56% for the first prescribed AAD. Rates of adherence to the guidelines 
increased significantly with a higher degree of prescriber specialization in arrhythmias (49%, 55%, and 60% for the PCP, GC, and EP 
groups, respectively, P=0.001) for first as well as for subsequent AAD. The choice of AAD also varied significantly by physician specialty 
with a higher use of Dofetilide and Class IC AAD and lower use of Amiodarone and Sotalol (P<0.001 for all comparisons) in the EP 
compared to other groups. 
Conclusion:  Adherence to guidelines in the AAD management of AF is low and dependent on prescriber specialty. The impact of 
physicians’ adherence to guidelines on AF recurrence and other patient outcomes deserves to be investigated.
